Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

500 trials

NCT06856161
Recruiting
A Novel Blood Test as a Biomarker in Mental Health
Not applicable · Canada · 1 site
Registry update: 5 Mar 2026
NCT06671977
Recruiting
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
Phase 1 · United States · 1 site
Registry update: 16 Jun 2026
NCT07924917
Recruiting
Individualized Temporally Interfering Electrical Stimulation in Major Depressive Disorder
Not applicable · China · 2 sites
Registry update: 9 Nov 2026
NCT06601140
Recruiting
Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode
Not applicable · France · 11 sites
Registry update: 19 Feb 2026
NCT07080489
Recruiting
Exploring the Role of the Prefrontal Cortex in Decision-Making
Not applicable · Switzerland · 1 site
Registry update: 31 Aug 2026
NCT06830044
Recruiting
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Phase 3 · Bulgaria, Czechia, Germany, Poland, United States · 57 sites
Registry update: 24 Sept 2026
NCT07247344
Recruiting
Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study
Not applicable · China · 1 site
Registry update: 25 Nov 2025
NCT06763081
Recruiting
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Not applicable · Canada · 2 sites
Registry update: 8 Sept 2025
NCT06805851
Recruiting
Impact of Depression on Thermoregulation
Not applicable · United States · 1 site
Registry update: 3 Feb 2026
NCT06860958
Recruiting
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
Phase 3 · Egypt · 1 site
Registry update: 4 May 2026
NCT06592833
Recruiting
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Phase 2 · United States · 1 site
Registry update: 6 Nov 2026
NCT06795451
Recruiting
Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
Phase 1/2 · United States · 1 site
Registry update: 3 Aug 2026
NCT07636694
Recruiting
Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)
Not applicable · Hong Kong · 1 site
Registry update: 16 Oct 2026
NCT06740396
Recruiting
Prevalence and Severity of Depression in Coronary Artery Disease Patients
Not applicable · Iraq · 1 site
Registry update: 18 Mar 2025
NCT05973786
Recruiting
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3 · Austria, Germany, Spain, United Kingdom, Greece, Italy · 13 sites
Registry update: 26 Sept 2025
Conflicting statuses (not updated in the registry for 13 months)
NCT06668571
Recruiting
Intravenous Ketamine for Treatment-Resistant Depression
Phase 2 · United States · 1 site
Registry update: 16 Oct 2026
NCT06619366
Recruiting
The Impact of Coach-guided Risk Communication on the Risk of Major Depression
Not applicable · Canada · 1 site
Registry update: 2 Sept 2025
NCT06547489
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Phase 2 · United States · 34 sites
Registry update: 3 Aug 2026
NCT06507787
Recruiting
Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects
Not applicable · France · 7 sites
Registry update: 3 Nov 2026
NCT06580145
Recruiting
Leucine in Midlife Depression
Phase 2 · United States · 1 site
Registry update: 11 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.